Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

ETView Viva-EB line of endobronchial blockers wins CE mark

ETView Medical has obtained European pre-market clearance for Viva-EB line of endobronchial blockers.

The Viva-EB product family are designed to provide endobronchial blockade of the right or left lung for thoracic surgical procedures requiring lung isolation.

ETView Medical CEO Bill Edelman said Viva-EB will be immediately available to the European thoracic surgical community following Medical Device Certification concurrence with the CE registration application.

"We anticipate significant clinical interest for VivaSight(TM)-DL when it is cleared for commercial distribution," Edelman added.

Viva-EB, which is compatible with the company’s patented VivaSight-SL, comprises of a sterile, single-use, steerable, balloon-tipped catheter guided under video imaging to a selected bronchial segment to affect balloon blockage of the distal airway.

Viva-EB is employed with an endotracheal tube when used in combination with a fibre-optic bronchoscope to blockade the right or left lung, according to the company.

The FDA granted 510(k) clearance for Viva-EB in June 2012, while additional pre-market regulatory filings in Europe and Asia are anticipated during 2012.